Concordance of copy number alterations using a common analytic pipeline for genome-wide analysis of Illumina and Affymetrix genotyping data: a report from the Children's Oncology Group

Ciriello, 2013, Emerging landscape of oncogenic signatures across human cancers, Nat Genet, 45, 1127, 10.1038/ng.2762 Futreal, 2004, A census of human cancer genes, Nat Rev Cancer, 4, 177, 10.1038/nrc1299 Conrad, 2010, Origins and functional impact of copy number variation in the human genome, Nature, 464, 704, 10.1038/nature08516 Curtis, 2009, The pitfalls of platform comparison: DNA copy number array technologies assessed, BMC Genomics, 10, 588, 10.1186/1471-2164-10-588 Pinto, 2011, Comprehensive assessment of array-based platforms and calling algorithms for detection of copy number variants, Nat Biotechnol, 29, 512, 10.1038/nbt.1852 Scherer, 2007, Challenges and standards in integrating surveys of structural variation, Nat Genet, 39, S7, 10.1038/ng2093 Gunnarsson, 2008, Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia—a comparative study of four differently designed, high resolution microarray platforms, Genes Chromosomes Cancer, 47, 697, 10.1002/gcc.20575 Mosén-Ansorena, 2012, Comparison of methods to detect copy number alterations in cancer using simulated and real genotyping data, BMC Bioinformatics, 13, 192, 10.1186/1471-2105-13-192 Mosén-Ansorena, 2013, Bivariate segmentation of SNP-array data for allele-specific copy number analysis in tumour samples, BMC Bioinformatics, 14, 84, 10.1186/1471-2105-14-84 Oros, 2013, Analysis of genomic abnormalities in tumors: a review of available methods for Illumina two-color SNP genotyping and evaluation of performance, Cancer Genet, 206, 103, 10.1016/j.cancergen.2013.03.001 Sung, 2013, Effectiveness of supportive care measures to reduce infections in pediatric AML: a report from the Children's Oncology Group, Blood, 121, 3573, 10.1182/blood-2013-01-476614 Cooper, 2011, AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology Group, Cancer, 118, 761, 10.1002/cncr.26190 Lange, 2008, Outcomes in CCG-2961, a Children's Oncology Group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from Children's Oncology Group, Blood, 111, 1044, 10.1182/blood-2007-04-084293 Diskin, 2008, Adjustment of genomic waves in signal intensities from whole-genome SNP genotyping platforms, Nucleic Acids Res, 36, e126, 10.1093/nar/gkn556 Van Loo, 2010, Allele-specific copy number analysis of tumors, PNAS, 107, 16910, 10.1073/pnas.1009843107 Maciejewski, 2009, Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies, Br J Haematol, 146, 479, 10.1111/j.1365-2141.2009.07757.x Keshavan, 2011, Dealing with sample aneuploidy and mosaicism using the ASCAT algorithm on different SNP array platforms, Cancer Genet, 204, 472, 10.1016/j.cancergen.2011.08.007 Dougherty, 2012, Clinical utilization of high-resolution single nucleotide polymorphism based oligonucleotide arrays in diagnostic studies of pediatric patients with solid tumors, Cancer Genet, 205, 42, 10.1016/j.cancergen.2012.01.014